RANDOLPH FRANK: Open Payments
NPI 1982614822 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 20 payments from 7 companies in 2025. Trend: 2023 $1,080 · 2024 $1,014 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $37 |
| TMS NeuroHealth Centers Inc. | 1 | $37 |
| Tris Pharma Inc | 1 | $17 |
Products named: REXULTI, CAPLYTA, APLENZIN, WELLBUTRIN, TRINTELLIX, ARISTADA, TMS NeuroHealth Centers Inc., Dyanavel XR.
Industry payments across VA — which companies pay providers there.
